# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-034672
Filing Date
2024-03-21
Accepted
2024-03-21 16:05:37
Documents
71
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | inkt-20231231.htm iXBRL | 10-K | 1873429
2 | EX-4.2 | inkt-ex4_2.htm | EX-4.2 | 88044
3 | EX-10.18 | inkt-ex10_18.htm | EX-10.18 | 99814
4 | EX-21.1 | inkt-ex21_1.htm | EX-21.1 | 6174
5 | EX-23.1 | inkt-ex23_1.htm | EX-23.1 | 3150
6 | EX-31.1 | inkt-ex31_1.htm | EX-31.1 | 15066
7 | EX-31.2 | inkt-ex31_2.htm | EX-31.2 | 15037
8 | EX-32.1 | inkt-ex32_1.htm | EX-32.1 | 8623
9 | EX-32.2 | inkt-ex32_2.htm | EX-32.2 | 8586
10 | EX-97.1 | inkt-ex97_1.htm | EX-97.1 | 46024
11 | GRAPHIC | img206969693_0.jpg | GRAPHIC | 27781
12 | GRAPHIC | img206969693_1.jpg | GRAPHIC | 37558
13 | GRAPHIC | img206969693_2.jpg | GRAPHIC | 47334
14 | GRAPHIC | img206969693_3.jpg | GRAPHIC | 26670
| Complete submission text file | 0000950170-24-034672.txt |  | 7035514

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
15 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | inkt-20231231.xsd | EX-101.SCH | 1023741
75 | EXTRACTED XBRL INSTANCE DOCUMENT | inkt-20231231_htm.xml | XML | 737171

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 212-994-8250
MiNK Therapeutics, Inc. (Filer) CIK: 0001840229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40908 | Film No.: 24771299
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)